Inventor · disambiguated record
Jing Li
Also filed as: LI JIN-PING · LI JING · LI JING-PING
75 granted patents·63 pending applications·291 citations·filing 1998–2025
98Inventor score
Files withWUXI BIOLOGICS IRELAND LTD32WUXI BIOLOGICS SHANGHAI CO LTD11CELL SIGNALING TECHNOLOGY INC6UNIV ILLINOIS5MILLENNIUM PHARM INC4
Top patents by PatentIndex Score
138 records- 0195US11078281B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2020·Granted Aug 3, 2021·8 cites·7 claims
- 0294US7902353B2Nucleic acid enzyme biosensors for ionsUNIV ILLINOIS·Filed 2007·Granted Mar 8, 2011·22 cites·14 claims
- 0394US6706474B1Nucleic acid enzyme biosensors for ionsUNIV ILLINOIS·Filed 2000·Granted Mar 16, 2004·76 cites·45 claims
- 0492US7638604B2Monoclonal antibodies against interleukin-22GENETICS INST LLC·Filed 2004·Granted Dec 29, 2009·32 cites·1 claims
- 0592US7192708B2Nucleic acid enzyme biosensors for ionsUNIV ILLINOIS·Filed 2003·Granted Mar 20, 2007·45 cites·69 claims
- 0691US7901684B2Antibodies against human IL-22 and uses thereforWYETH LLC·Filed 2007·Granted Mar 8, 2011·14 cites·10 claims
- 0790US11795221B2Monoclonal antibody against human LAG-3, method for preparing the same, and use thereofWUXI BIOLOGICS IRELAND LTD·Filed 2019·Granted Oct 24, 2023·3 cites·19 claims
- 0889US11008391B2Anti-PD-1 antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2016·Granted May 18, 2021·4 cites·2 claims
- 0986US11845796B2Bispecific polypeptide complexesWUXI BIOLOGICS IRELAND LTD·Filed 2018·Granted Dec 19, 2023·2 cites·27 claims
- 1086US11643465B2Anti-PD-1 antibodiesWUXI BIOLOGIES IRELAND LTD·Filed 2021·Granted May 9, 2023·1 cites·9 claims
- 1184US12240906B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2023·Granted Mar 4, 2025·0 cites·6 claims
- 1284US11377486B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jul 5, 2022·2 cites·6 claims
- 1384US2025313634A1Novel anti-pd-l1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2024·Application pending·0 cites
- 1483US11643463B2Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)WUXI BIOLOGIES SHANGHAI CO LTD·Filed 2017·Granted May 9, 2023·3 cites·4 claims
- 1582US12371493B2Monoclonal antibody against human LAG-3, method for preparing the same, and use thereofWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2023·Granted Jul 29, 2025·0 cites·18 claims
- 1681US6127573AOxidaton of primary alcohols to carboxylic acids with a TEMPO catalyst using NaClO2 and NaClOMERCK & CO INC·Filed 1999·Granted Oct 3, 2000·27 cites·13 claims
- 1780US11661452B2Anti-lag-3 antibody polypeptideWUXI BIOLOGICS IRELAND LTD·Filed 2019·Granted May 30, 2023·2 cites·22 claims
- 1880US9220264B2Multimeric forms of antimicrobial peptidesSINGAPORE HEALTH SERV PTE LTD·Filed 2013·Granted Dec 29, 2015·2 cites·18 claims
- 1978US9181326B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2013·Granted Nov 10, 2015·2 cites·7 claims
- 2077US10981995B2Anti-PD-L1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2016·Granted Apr 20, 2021·1 cites·17 claims
- 2176US2023348602A1Novel anti-pd-1 antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2023·Application pending·0 cites
- 2274US9545453B2CXCR4 inhibiting carriers for nucleic acid deliveryUNIV WAYNE STATE·Filed 2012·Granted Jan 17, 2017·2 cites·17 claims
- 2374US2024124586A1Novel bispecific polypeptide complexesWUXI BIOLOGICS IRELAND LTD·Filed 2023·Application pending·0 cites
- 2473US12180282B2Anti-PD-L1 antibodiesWUXI BIOLOGICS SHANGHAI CO LTD·Filed 2021·Granted Dec 31, 2024·0 cites·18 claims
- 2573US10688153B2Peptides and method for treatment of cardiac arrestUNIV ILLINOIS·Filed 2016·Granted Jun 23, 2020·1 cites·9 claims
- 2673US8809262B2Multimeric forms of antimicrobial peptidesBEUERMAN ROGER W·Filed 2009·Granted Aug 19, 2014·4 cites·18 claims
- 2773US8513218B2Derivatives of 1-amino-2-cyclopropylethylboronic acidFLEMING PAUL E·Filed 2011·Granted Aug 20, 2013·1 cites·22 claims
- 2873US8187603B2Antibodies to human IL-22GILL DAVINDER S·Filed 2009·Granted May 29, 2012·1 cites·24 claims
- 2973US2024101676A1The novel monoclonal antibodies to programmed death 1 (pd-1)CSTONE PHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 3073US2024301067A1Novel anti-pd-1 antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2024·Application pending·0 cites
- 3172US11414487B2Monoclonal antibodies to programmed death 1 (PD-1)CSTONE PHARMACEUTICALS·Filed 2016·Granted Aug 16, 2022·1 cites·18 claims
- 3272US9249231B2Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motifCOMB MICHAEL·Filed 2011·Granted Feb 2, 2016·2 cites·16 claims
- 3372US8206915B2Nucleic acid enzyme biosensors for ionsLU YI·Filed 2011·Granted Jun 26, 2012·1 cites·22 claims
- 3472US2025082763A1Combination drug for treating triple-negative breast cancerHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3572US2025163156A1Novel monoclonal antibodies to cytotoxic t-lymphocyte-associated protein 4 (ctla-4)WUXI BIOLOGICS SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 3672US2025082764A1Drug for treating triple negative breast cancerHINOVA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3771US8470993B2Nucleic acid encoding antibody to human IL-22GILL DAVINDER S·Filed 2012·Granted Jun 25, 2013·1 cites·19 claims
- 3871US7091330B2Cloning and characterization of a CD2 binding protein (CD2BP2)HARVARD COLLEGE·Filed 2001·Granted Aug 15, 2006·2 cites·17 claims
- 3969US8182817B2Antibodies to human IL-22GILL DAVINDER S·Filed 2010·Granted May 22, 2012·1 cites·20 claims
- 4069US2024391971A1Gdf15 fusion proteins and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 4169US2024343770A1Gdf15 fusion proteins and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 4269US2024350588A1Gdf15 fusion proteins and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 4368US12485298B2Anti-CD3epsilon antibodiesWUXI BIOLOGICS IRELAND LTD·Filed 2022·Granted Dec 2, 2025·0 cites·19 claims
- 4467US2023014722A1Novel Monoclonal Antibodies to Programmed DEATH (PD-1)CSTONE PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 4566US8664200B2Derivatives of 1-amino-2-cyclobutylethylboronic acidFLEMING PAUL E·Filed 2009·Granted Mar 4, 2014·0 cites·13 claims
- 4666US2025381306A1Compositions and methods for treating diabetic cardiomyopathyUNIV UTAH RES FOUND·Filed 2023·Application pending·0 cites
- 4766US2024101708A1Multispecific Binding Protein Degrader Platform and Methods of UseGENENTECH INC·Filed 2023·Application pending·0 cites
- 4865US2025042964A1Method of treating nash using a long-acting mutant human fibroblast growth factorTASLY BIOPHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 4964US11352418B2Analysis of ubiquitinated polypeptidesCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jun 7, 2022·0 cites·8 claims
- 5064US11267885B2CD47 antigen binding unit and uses thereofZLIP HOLDING LTD·Filed 2018·Granted Mar 8, 2022·2 cites·21 claims
Showing the top 50 of 138 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jing Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →